Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-07-05FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Lansoprazole from Mylan Pharmaceuticals Inc. under an existing ANDA, approving a generic version…
-
FDA approval · 2024-05-28FDA Approved: FAMOTIDINE — Original Application (LEADER/ Cardinal Health 110, Inc.)
FDA approved the original ANDA for famotidine from LEADER/ Cardinal Health 110, Inc., providing a generic version of famotidine.
-
FDA approval · 2024-05-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approves a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Inc., authorizing changes to an existing generic prod…
-
FDA approval · 2024-05-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole from Mylan Pharmaceuticals Inc., indicating an amendment to the approved generic pr…
-
FDA approval · 2024-04-30FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' esomeprazole magnesium as a generic product under an Original Application (ANDA 207198). The approval…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-23FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for pantoprazole sodium (generic pantoprazole) from Ajanta Pharma USA Inc. under ANDA217416.
-
FDA approval · 2024-04-15FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Piramal Critical Care)
The FDA approved a supplemental application for Pantoprazole Sodium for Injection (IV), submitted by Piramal Critical Care, enabling its con…
-
FDA approval · 2024-04-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for pantoprazole sodium from Edenbridge Pharmaceuticals LLC., indicating an approved modification un…
-
FDA approval · 2024-03-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for pantoprazole sodium submitted by Eugia US LLC.
-
FDA approval · 2024-02-23FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for Lansoprazole submitted by Medcore LLC. The snippet does not specify the exact changes covere…
-
FDA approval · 2024-02-14FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter's original application for pantoprazole sodium in 0.9% sodium chloride. It is a proton pump inhibitor used to treat acid…
-
FDA approval · 2024-02-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole filed by Mylan Pharmaceuticals (ANDA 090763).
-
FDA approval · 2024-02-05FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium submitted by Zydus Pharmaceuticals USA Inc., enabling the generic esomepr…
-
FDA approval · 2024-01-19FDA Approved: DEXLANSOPRAZOLE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approval of Mylan's original ANDA for dexlansoprazole, providing a generic version of the proton pump inhibitor to treat acid-related di…
-
FDA approval · 2024-01-16FDA Approved: FAMOTIDINE — Original Application (DR. REDDY'S LABORATORIES INC)
The FDA approved the original ANDA for famotidine from Dr. Reddy's Laboratories, authorizing a generic version of famotidine. This is a rout…
-
FDA approval · 2024-01-11FDA Approved: OMEPRAZOLE SODIUM BICARBONATE — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for omeprazole sodium bicarbonate (ANDA 207476), confirming its marketing approva…
-
FDA approval · 2024-01-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Biocon Pharma Inc.,)
The FDA approved Biocon Pharma Inc.'s supplemental application for Esomeprazole Magnesium, a generic esomeprazole product, under ANDA 213486…
-
FDA approval · 2023-12-27FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Zhejiang Yongtai Pharmaceutical Co., Ltd)
FDA approved Esomeprazole Magnesium from Zhejiang Yongtai Pharmaceutical Co., Ltd under an Original Application (ANDA217022).
-
FDA approval · 2023-12-26FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves a supplemental application for a generic omeprazole and sodium bicarbonate product from Ajanta Pharma USA Inc.
-
FDA approval · 2023-12-14FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) from Kenvue Brands LLC, under NDA 020325.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety [Phase 4]
Phase 4 trial update evaluating long-term safety of vonoprazan in patients with erosive esophagitis; results posted.
-
FDA approval · 2023-12-11FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s Pantoprazole Sodium as an original-application generic pantoprazole product.
-
FDA approval · 2023-11-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Esomeprazole Magnesium from Aurobindo Pharma Limited, indicating regulatory approval of an a…
-
FDA approval · 2023-11-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Wal-Mart Stores, Inc.)
The FDA approved Wal-Mart Stores, Inc.'s supplemental application for esomeprazole magnesium, a generic proton pump inhibitor.
-
FDA approval · 2023-11-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for esomeprazole magnesium from Sun Pharmaceutical Industries, Inc. under an ANDA process, indicatin…